Pseudomembranous Colitis: Unveiling an Infrequent Culprit Beyond —A Case Report

Immunotherapy-induced pseudomembranous colitis (PMC) is an uncommon but increasingly recognized adverse effect of immune checkpoint inhibitors, particularly in patients with advanced malignancies. We present a case of a 68-year-old male with gastric adenocarcinoma undergoing treatment with immunothe...

Full description

Saved in:
Bibliographic Details
Main Authors: Manasa Ginjupalli MD, Jayalekshmi Jayakumar MD, Praneeth Bandaru MD, Vikash Kumar MD, Arnold Forlemu MD, Giovannie Isaac Coss MD, Denzil Etienne MD, Madhavi Reddy MD, FACG
Format: Article
Language:English
Published: SAGE Publishing 2025-06-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/23247096251347401
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849422180990844928
author Manasa Ginjupalli MD
Jayalekshmi Jayakumar MD
Praneeth Bandaru MD
Vikash Kumar MD
Arnold Forlemu MD
Giovannie Isaac Coss MD
Denzil Etienne MD
Madhavi Reddy MD, FACG
author_facet Manasa Ginjupalli MD
Jayalekshmi Jayakumar MD
Praneeth Bandaru MD
Vikash Kumar MD
Arnold Forlemu MD
Giovannie Isaac Coss MD
Denzil Etienne MD
Madhavi Reddy MD, FACG
author_sort Manasa Ginjupalli MD
collection DOAJ
description Immunotherapy-induced pseudomembranous colitis (PMC) is an uncommon but increasingly recognized adverse effect of immune checkpoint inhibitors, particularly in patients with advanced malignancies. We present a case of a 68-year-old male with gastric adenocarcinoma undergoing treatment with immunotherapy and chemotherapy, who developed symptoms of PMC. Workup for Clostridium difficile and other common etiologies was negative. Colonoscopy revealed severe mucosal congestion and yellowish-green exudates, consistent with PMC. Based on the biopsy results and clinical presentation, after excluding common etiologies, immunotherapy-induced PMC was suspected. The patient responded to steroid therapy, with gradual improvement and a tapering regimen upon discharge. This case underscores the diagnostic challenges in identifying the etiology of PMC, particularly when it presents with diffuse involvement of the colon, which is an uncommon presentation for immunotherapy-related colitis. The overlap in clinical, endoscopic, and histopathological findings with other forms of colitis, such as Clostridium difficile infection (CDI) and inflammatory bowel disease, highlights the need for heightened awareness among clinicians. This case highlights the diagnostic challenges in recognizing immunotherapy-induced PMC, particularly with atypical, diffuse colonic involvement. The overlapping features with other colitis make timely diagnosis difficult. Further research is needed to refine diagnostic criteria and management strategies for immunotherapy induced colitis (IMC).
format Article
id doaj-art-f58320c2d85c4ccd89f1e29e64994b83
institution Kabale University
issn 2324-7096
language English
publishDate 2025-06-01
publisher SAGE Publishing
record_format Article
series Journal of Investigative Medicine High Impact Case Reports
spelling doaj-art-f58320c2d85c4ccd89f1e29e64994b832025-08-20T03:31:11ZengSAGE PublishingJournal of Investigative Medicine High Impact Case Reports2324-70962025-06-011310.1177/23247096251347401Pseudomembranous Colitis: Unveiling an Infrequent Culprit Beyond —A Case ReportManasa Ginjupalli MD0Jayalekshmi Jayakumar MD1Praneeth Bandaru MD2Vikash Kumar MD3Arnold Forlemu MD4Giovannie Isaac Coss MD5Denzil Etienne MD6Madhavi Reddy MD, FACG7Department of Internal Medicine, The Brooklyn Hospital Centre, NY, USADepartment of Internal Medicine, The Brooklyn Hospital Centre, NY, USADepartment of Gastroenterology, The Brooklyn Hospital Centre, NY, USADepartment of Gastroenterology, Creighton University, Phoenix, AZ, USADepartment of Gastroenterology, The Brooklyn Hospital Centre, NY, USADepartment of Gastroenterology, Rush University Medical Centre, Chicago, IL, USADepartment of Gastroenterology, The Brooklyn Hospital Centre, NY, USADepartment of Gastroenterology, The Brooklyn Hospital Centre, NY, USAImmunotherapy-induced pseudomembranous colitis (PMC) is an uncommon but increasingly recognized adverse effect of immune checkpoint inhibitors, particularly in patients with advanced malignancies. We present a case of a 68-year-old male with gastric adenocarcinoma undergoing treatment with immunotherapy and chemotherapy, who developed symptoms of PMC. Workup for Clostridium difficile and other common etiologies was negative. Colonoscopy revealed severe mucosal congestion and yellowish-green exudates, consistent with PMC. Based on the biopsy results and clinical presentation, after excluding common etiologies, immunotherapy-induced PMC was suspected. The patient responded to steroid therapy, with gradual improvement and a tapering regimen upon discharge. This case underscores the diagnostic challenges in identifying the etiology of PMC, particularly when it presents with diffuse involvement of the colon, which is an uncommon presentation for immunotherapy-related colitis. The overlap in clinical, endoscopic, and histopathological findings with other forms of colitis, such as Clostridium difficile infection (CDI) and inflammatory bowel disease, highlights the need for heightened awareness among clinicians. This case highlights the diagnostic challenges in recognizing immunotherapy-induced PMC, particularly with atypical, diffuse colonic involvement. The overlapping features with other colitis make timely diagnosis difficult. Further research is needed to refine diagnostic criteria and management strategies for immunotherapy induced colitis (IMC).https://doi.org/10.1177/23247096251347401
spellingShingle Manasa Ginjupalli MD
Jayalekshmi Jayakumar MD
Praneeth Bandaru MD
Vikash Kumar MD
Arnold Forlemu MD
Giovannie Isaac Coss MD
Denzil Etienne MD
Madhavi Reddy MD, FACG
Pseudomembranous Colitis: Unveiling an Infrequent Culprit Beyond —A Case Report
Journal of Investigative Medicine High Impact Case Reports
title Pseudomembranous Colitis: Unveiling an Infrequent Culprit Beyond —A Case Report
title_full Pseudomembranous Colitis: Unveiling an Infrequent Culprit Beyond —A Case Report
title_fullStr Pseudomembranous Colitis: Unveiling an Infrequent Culprit Beyond —A Case Report
title_full_unstemmed Pseudomembranous Colitis: Unveiling an Infrequent Culprit Beyond —A Case Report
title_short Pseudomembranous Colitis: Unveiling an Infrequent Culprit Beyond —A Case Report
title_sort pseudomembranous colitis unveiling an infrequent culprit beyond a case report
url https://doi.org/10.1177/23247096251347401
work_keys_str_mv AT manasaginjupallimd pseudomembranouscolitisunveilinganinfrequentculpritbeyondacasereport
AT jayalekshmijayakumarmd pseudomembranouscolitisunveilinganinfrequentculpritbeyondacasereport
AT praneethbandarumd pseudomembranouscolitisunveilinganinfrequentculpritbeyondacasereport
AT vikashkumarmd pseudomembranouscolitisunveilinganinfrequentculpritbeyondacasereport
AT arnoldforlemumd pseudomembranouscolitisunveilinganinfrequentculpritbeyondacasereport
AT giovannieisaaccossmd pseudomembranouscolitisunveilinganinfrequentculpritbeyondacasereport
AT denziletiennemd pseudomembranouscolitisunveilinganinfrequentculpritbeyondacasereport
AT madhavireddymdfacg pseudomembranouscolitisunveilinganinfrequentculpritbeyondacasereport